CD19 and leukemia: A UPenn team recently reported a patient relapsing after infusion of anti-CD19 CAR T cells with CD19-negative leukemia that aberrantly expressed the anti-CD19 CAR because the CAR gene was unintentionally introduced into a single leukemic B cell during T-cell manufacturing [36].